| International Stem Cell Corporation (OTCBB:ISCO) (www.internationalstemcell.com), a California-based stem cell therapeutics company, today announced that the Company has been invited to present at the 20th Annual Roth Capital Partners Orange County Growth Stock Conference to be held at The Ritz Carlton Laguna Niguel,located at One Ritz-Carlton Drive, Dana Point, California 92629. ISCO is scheduled to present on Tuesday, February 19, 2008 at 2:00 P.M., Pacific Time. Chairman and Chief Executive Officer Kenneth Aldrich will represent the company. The Roth Conference, the largest of its kind in the nation, is expected to attract over 1000 institutional investors or buyside attendees. Interested parties can access a live audio web cast of this presentation at: http://www.wsw.com/webcast/roth16/stemcell/. A replay of this presentation will be available at the same location. ABOUT INTERNATIONAL STEM CELL CORPORATION: International Stem Cell Corporation (ISCO) is a California biotechnology company focused on developing therapeutic and research products. ISCO's technology, Parthenogenesis, results in the creation of pluripotent human stem cell lines from unfertilized human eggs. ISCO scientists also have created the first Parthenogenic homozygous stem cell line (phSC-Hhom-4) that can be a source of therapeutic cells that will not be immune rejected after transplantation into millions of individuals of differing sexes, ages and racial groups. These advancements offer the potential to create the first true "Stem Cell Bank" and address ethical issues by eliminating the need to use or destroy fertilized embryos. ISCO also produces and markets specialized cells and growth media worldwide for therapeutic research through its subsidiary Lifeline Cell Technology. For more information, visit the ISCO website at: www.internationalstemcell.com. To subscribe to receive ongoing corporate communications please click on the following link: http://www.b2i.us/irpass.asp?BzID=1468&to=ea&s=0. About Roth Capital OC Conference ROTH Conferences are one of the largest in the nation for micro and small cap companies. Now in its 20th year, the ROTH Annual OC Conference will feature presentations from over 300 small-cap companies. The distinguished list of presenting companies have been identified by ROTH's award-winning research team and are representative of a broad spectrum of sectors, including Technology, Healthcare, Energy and Industrial as well as Consumer Products. The conference will be held February 18-21st, 2008. Forward-Looking Statements Statements pertaining to future financial and/or operating results, future growth in research, technology, clinical development and potential opportunities for the company and its subsidiary, along with other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements. Any statements that are not historical fact (including, but not limited to statements that contain words such as "will,""believes,""plans,""anticipates,""expects,""estimates,") should also be considered to be forward-looking statements. Forward-looking statements involve risks and uncertainties, including, without limitation, risks inherent in the development and/or commercialization of potential products, uncertainty in the results of clinical trials or regulatory approvals, need and ability to obtain future capital, and maintenance of intellectual property rights. Actual results may differ materially from the results anticipated in these forward-looking statements and as such should be evaluated together with the many uncertainties that affect the company's business, particularly those mentioned in the cautionary statements found in the company's Securities and Exchange Commission filings. The company disclaims any intent or obligation to update these forward-looking statements. |
